6. Anti-Inflammatory Drugs and Risks
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation but can carry cardiovascular risks, including increased chances of blood clots. Some NSAIDs may promote platelet aggregation or affect blood vessel function, contributing to thrombus formation.
Patients with existing cardiovascular disease, hypertension, or clotting disorders should use these medications cautiously and under medical supervision. Alternative pain management strategies may be preferable for high-risk individuals.
7. Diet Pills and Appetite Suppressants
Certain diet pills and appetite suppressants, especially those containing stimulants or sympathomimetic compounds, can elevate heart rate and blood pressure, creating a pro-thrombotic state. These drugs may also cause vasoconstriction, increasing the likelihood of clot formation.
Due to these risks, many appetite suppressants require prescription oversight, and some have been withdrawn from the market. Patients considering weight loss medications should undergo cardiovascular risk assessment and be monitored regularly.
8. COVID-19 Treatments and Clot Risk
Some treatments used during COVID-19 illness, particularly certain antiviral and immunomodulatory medications, have been linked to rare instances of thrombotic complications. COVID-19 itself is associated with a hypercoagulable state, increasing clot risk independently.
Healthcare providers weigh the benefits and risks when prescribing these therapies and monitor patients closely. Awareness of clot symptoms and rapid intervention remain essential during and after COVID-19 treatment.
